HOME >> MEDICINE >> NEWS
Growth factors given with chemotherapy associated with increased risk of blood diseases

Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7 Journal of the National Cancer Institute. The authors note that the absolute risk of the conditions is very small, but that risk should still be taken into consideration when making treatment decisions.

The growth factors granulocyte or granulocyte-macrophage colony-stimulating factor (G-CSF or GM-CSF) have been used to reduce the risk of infections from neutropenia, an abnormally low count of a certain type of white blood cell that helps control infections. Chemotherapy destroys these cells, and it is difficult for the body to quickly replace them.

However, there is some concern that these growth factors may keep cells alive that have been mutated by chemotherapy. Ordinarily, certain cell processes would recognize such damage and instruct the cell to die, but growth factors may save the mutant cell, allowing it to develop into a cancer called acute myelocytic leukemia (AML). There's also concern about the risk of a disease called myelodysplastic syndrome (MDS), in which the bone marrowwhich produces blood cellsdoes not function normally. Indeed, some studies have hinted that cancer patients who receive growth factors with chemotherapy may have an increased risk of these two diseases.

Dawn Hershman, M.D., of the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center and New York Presbyterian Hospital, and colleagues set out to determine the association between G-CSF or GM-CSF use and the risk of AML or MDS among women treated with chemotherapy for early-stage breast cancer. Using a database that links cancer registry data from the Surveillance, Epidemiology, and End Results (SEER) program with data from Medicare, th
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
6-Feb-2007


Page: 1 2

Related medicine news :

1. Growth hormone stimulators improve physical function in older adults
2. Growth-factor therapy improves endothelial cell production and mobility in arterial disease
3. Growth factor protects brain against damage from stroke
4. Growth patterns into childhood reveal risk of coronary heart disease later in life
5. Growth hormone illegal for off-label anti-aging use, study warns
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Study, meta-analysis examine factors associated with death from heatstroke
8. Parents and schools, major factors in China obesity boom
9. Smoking and sleep top the list of lifestyle factors impacting oral health
10. Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
11. Green tea compound suppresses factors causing cartilage, bone destruction in arthritis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... ... Learning (SEL) program, has been named to the inaugural list of Best Digital ... , This recognition honors electronic resources that provide enhanced learning and curriculum ...
(Date:8/5/2020)... ... August 05, 2020 , ... ChronWell, a ... Director of Clinical Services and Myron Falchuk, M.D. as an Advisor, to further ... has achieved incredible growth as demand for remote care management services soared amidst ...
(Date:8/5/2020)... AUSTIN, Texas (PRWEB) , ... August 04, 2020 ... ... and older adults living with memory impairment, has announced the Best Memory Care ... location, access to experts, facility features and amenities. , According to the ...
(Date:8/3/2020)... FORT WORTH, Texas (PRWEB) , ... August 03, ... ... biopharmaceutical company, today announced enrollment of the first patients with first-line advanced pancreatic ... the ongoing phase 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is ...
(Date:7/22/2020)... N.Y. (PRWEB) , ... July 22, 2020 , ... Whatever ... wants them. “Some people may like a summer glow,” notes Angie Seelal, a Certified ... likes the dark spots that show up years later and make us look older.” ...
Breaking Medicine News(10 mins):
(Date:8/7/2020)... ... August 07, 2020 , ... ... blog educating readers on what intensive outpatient programs are and who ... to overcome their addiction, many turn to intensive outpatient programs provided by addiction ...
(Date:8/5/2020)... ... August 04, 2020 , ... The Pulmonary Wellness Foundation (PWF), a New ... patients for nearly three decades, today announced the launch of the nation’s first online ... program kicked off Sunday, August 2 and meets on Wednesday and Sunday evenings at ...
(Date:8/3/2020)... SEATTLE (PRWEB) , ... August 03, 2020 , ... ... announced that an agreement has been reached, to amend and restate IDRI’s license ... of the United States and Canada). Under the amendment, the parties have agreed ...
Breaking Medicine Technology:
Cached News: